These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 13582205)
1. The treatment of vitiligo with psoralen derivatives. LEVAI M AMA Arch Derm; 1958 Nov; 78(5):597-606. PubMed ID: 13582205 [No Abstract] [Full Text] [Related]
2. Treatment of vitiligo with psoralen derivatives. GEORGE WM; BURKS JW AMA Arch Derm; 1955 Jan; 71(1):14-8. PubMed ID: 13217464 [No Abstract] [Full Text] [Related]
3. Psoralen prophylaxis against skin cancer: progress of field trials. HOPKINS CE J Invest Dermatol; 1959 Feb; 32(2, Part 2):383-6. PubMed ID: 13641815 [No Abstract] [Full Text] [Related]
4. Hydrocortisone ointment in psoralen-treated vitiligo; effect in preventing dermatitis. GEORGE W; BURKS JW AMA Arch Derm; 1955 Nov; 72(5):458-61. PubMed ID: 13257922 [No Abstract] [Full Text] [Related]
5. A comparative clinical evaluation of trimethylpsoralen, psoralen and 8-methoxypsoralen in treating vitiligo. Sehgal VN Int J Dermatol; 1975 Apr; 14(3):205-8. PubMed ID: 1126780 [TBL] [Abstract][Full Text] [Related]
6. Investigations on the effect of psoralen derivatives on blood sugar and glutathione. EL-MOFTY A; EL-MOFTY AM; ABDELAL H; EL-HAWARY MF AMA Arch Derm; 1959 Jul; 80(1):53-5. PubMed ID: 13660499 [No Abstract] [Full Text] [Related]
7. Studies on the mode of action of psoralen derivatives. I. Their effect on copper and glutathione levels in blood and liver. EL-MOFTY A; EL-MOFTY AM; ABDELAL H; EL-HAWARY MF J Invest Dermatol; 1959 Jun; 32(6):645-9. PubMed ID: 13665076 [No Abstract] [Full Text] [Related]
8. Studies on the mode of action of psoralen derivatives. II. The pituitary adrenal axis control of copper metabolism and its response to psoralens. EL-MOFTY A; EL-MOFTY AM; ABDELAL H; EL-HAWARY MF J Invest Dermatol; 1959 Jun; 32(6):651-9. PubMed ID: 13665077 [No Abstract] [Full Text] [Related]
10. Evaluation of methoxsalen in the treatment of vitiligo. LONDON ID J Invest Dermatol; 1959 Feb; 32(2, Part 2):315-7. PubMed ID: 13641801 [No Abstract] [Full Text] [Related]
12. Clinical experiences with methoxsalen in the treatment of vitiligo. ELLIOTT JA J Invest Dermatol; 1959 Feb; 32(2, Part 2):311-3. PubMed ID: 13641800 [No Abstract] [Full Text] [Related]
13. The clinical use of 8-methoxypsoralen. GOLDBERG LC Antibiotic Med Clin Ther (New York); 1959 Jul; 6(7):407-11. PubMed ID: 13661857 [No Abstract] [Full Text] [Related]
17. Results in the treatment of vitiligo with 8-methoxypsoralen. SHELDON SA; HARRELL ER; CURTIS AC AMA Arch Derm; 1956 Jul; 74(1):9-13. PubMed ID: 13325954 [No Abstract] [Full Text] [Related]
18. Clinical and experimental studies with 8-methoxypsoralen in vitiligo. LERNER AB; DENTON CR; FITZPATRICK TB J Invest Dermatol; 1953 Apr; 20(4):299-314. PubMed ID: 13052979 [No Abstract] [Full Text] [Related]
19. The treatment of vitiligo with 8-methoxypsoralen. ELLIOTT JA South Med J; 1956 Jul; 49(7):691-7. PubMed ID: 13337429 [No Abstract] [Full Text] [Related]
20. Local application of 8-methoxypsoralen in vitiligo. KELLY EW; PINKUS H J Invest Dermatol; 1955 Dec; 25(6):453-6. PubMed ID: 13286532 [No Abstract] [Full Text] [Related] [Next] [New Search]